Cite
Randomized trial of early corticosteroid reduction vs. regular-dose corticosteroid maintenance in combination with tacrolimus and mycophenolate mofetil in living donor kidney transplant recipients: the Brazilian CORRETA trial.
MLA
Garcia, Valter D., et al. “Randomized Trial of Early Corticosteroid Reduction vs. Regular-Dose Corticosteroid Maintenance in Combination with Tacrolimus and Mycophenolate Mofetil in Living Donor Kidney Transplant Recipients: The Brazilian CORRETA Trial.” Clinical Transplantation, vol. 24, no. 4, July 2010, pp. E109–15. EBSCOhost, https://doi.org/10.1111/j.1399-0012.2009.01185.x.
APA
Garcia, V. D., Carvalho, D. B. M., Gonçalves, R. T., Cavalcanti, R. L., Campos, H. H., Abbud-Filho, M., & Lobao-Neto, A. A. (2010). Randomized trial of early corticosteroid reduction vs. regular-dose corticosteroid maintenance in combination with tacrolimus and mycophenolate mofetil in living donor kidney transplant recipients: the Brazilian CORRETA trial. Clinical Transplantation, 24(4), E109–E115. https://doi.org/10.1111/j.1399-0012.2009.01185.x
Chicago
Garcia, Valter D., Deise B. M. Carvalho, Renato T. Gonçalves, Ruy L. Cavalcanti, Henry H. Campos, Mário Abbud-Filho, and Abner A. Lobao-Neto. 2010. “Randomized Trial of Early Corticosteroid Reduction vs. Regular-Dose Corticosteroid Maintenance in Combination with Tacrolimus and Mycophenolate Mofetil in Living Donor Kidney Transplant Recipients: The Brazilian CORRETA Trial.” Clinical Transplantation 24 (4): E109–15. doi:10.1111/j.1399-0012.2009.01185.x.